| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.0022 | 0.9 |